Corrections needed to 2016 ESC and AHA guidelines on heart failure

Lancet Diabetes Endocrinol. 2017 May;5(5):325-326. doi: 10.1016/S2213-8587(17)30102-X. Epub 2017 Apr 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
  • Guidelines as Topic
  • Heart Failure / chemically induced*
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Incretins / blood

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Incretins